首页> 外文期刊>International journal of infectious diseases : >Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale
【24h】

Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale

机译:Covid-19相关ARDS和急性CORMONALE的重组组织纤溶酶原处理

获取原文
获取外文期刊封面目录资料

摘要

Existing literature highlights the fact that patients with COVID-19 exhibit alterations in the coagulation process and are associated with respiratory and cardiovascular diseases, including acute respiratory distress syndrome and acute cor pulmonale. In this report, we describe the effects of systemic thrombolysis on acute cor pulmonale in a patient suffering from COVID-19. We demonstrated that systemic thrombolysis successfully improved the hemodynamics of our patient and resulted in a prominent reduction in hypercapnia, alveolar dead space, and ventilatory ratio.
机译:现有文献突出了Covid-19患者在凝血过程中表现出改变的事实,并与呼吸和心血管疾病有关,包括急性呼吸窘迫综合征和急性COR肺脉络。 在本报告中,我们描述了全身溶栓对患有Covid-19患者急性肺肺脉的影响。 我们证明,全身溶栓成功改善了我们患者的血流动力学,导致高胶质虫,肺泡死区和通风率突出。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号